Zentalis Pharmaceuticals Inc (ZNTL)

09:32 AM

Is Zentalis Pharmaceuticals Inc. a growth stock or a value stockFree Trend-Following Techniques - jammulinksnews.com

09:32 AM

07:29 AM

How does Zentalis Pharmaceuticals Inc. compare to its industry peersGet expert analysis on top stock picks - jammulinksnews.com

07:29 AM

07:14 AM

Will Zentalis Pharmaceuticals Inc. Stock Benefit from AI and Green Energy TrendsFree Capital Allocation Plans - beatles.ru

07:14 AM

05:59 AM

When is the best time to exit Zentalis Pharmaceuticals Inc.Smart Stock Forecast Using AI Algorithms - Newser

05:59 AM

05:27 AM

Why Zentalis Pharmaceuticals Inc. stock attracts strong analyst attentionSecure Asset Flow and Trend Pattern Analysis - Newser

05:27 AM

01:22 AM

What is the dividend policy of Zentalis Pharmaceuticals Inc. stockSuperior returns - jammulinksnews.com

01:22 AM

Jul 27, 2025

When is Zentalis Pharmaceuticals Inc. stock expected to show significant growthMaximize your returns with smart trade entries - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

What are analysts’ price targets for Zentalis Pharmaceuticals Inc. in the next 12 monthsMaster the art of timing market moves - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

How volatile is Zentalis Pharmaceuticals Inc. stock compared to the marketMassive profits - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

What are Zentalis Pharmaceuticals Inc. company’s key revenue driversUnbelievable profit margins - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

What catalysts could drive Zentalis Pharmaceuticals Inc. stock higher in 2025Maximize your gains with professional insights - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

What is the risk reward ratio of investing in Zentalis Pharmaceuticals Inc. stockInvest smarter with real-time trading signals - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

Sectors Driving Future Growth for Zentalis Pharmaceuticals Inc. StockFree Access to Community - Newser

Jul 27, 2025

Jul 25, 2025

What makes Zentalis Pharmaceuticals Inc. stock price move sharplyConsistent High Return Strategy - Newser

Jul 25, 2025

Jul 25, 2025

What drives Zentalis Pharmaceuticals Inc. stock priceFree Technical Analysis Support - PrintWeekIndia

Jul 25, 2025

Jul 23, 2025

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) is favoured by institutional owners who hold 59% of the company - Yahoo Finance

Jul 23, 2025

Jul 23, 2025

Is Zentalis Pharmaceuticals Inc. a good long term investmentFree Technical Analysis Support - Autocar Professional

Jul 23, 2025

Jul 23, 2025

What analysts say about Zentalis Pharmaceuticals Inc. stockFree Stock Selection - Autocar Professional

Jul 23, 2025

Jul 23, 2025

Zentalis Pharmaceuticals Inc. Stock Analysis and ForecastAccelerated capital growth - Autocar Professional

Jul 23, 2025

Jul 15, 2025

How Zentalis Pharmaceuticals Inc. stock performs during market volatilityDaily Swing Candidates - Newser

Jul 15, 2025

Jul 14, 2025

Insider Stock Buyers At Zentalis Pharmaceuticals Recouped Some Losses This Week - simplywall.st

Jul 14, 2025

Jul 12, 2025

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Given Average Rating of “Moderate Buy” by Brokerages - Defense World

Jul 12, 2025

Jul 11, 2025

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛

Jul 11, 2025

Jul 07, 2025

Wealth Enhancement Advisory Services LLC Purchases 33,958 Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

Jul 07, 2025

Jul 02, 2025

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Jul 02, 2025

Jul 01, 2025

Zentalis Grants $1.19 Per Share Stock Options Package Under Nasdaq Compliance Rules - Stock Titan

Jul 01, 2025

Jun 30, 2025

Zentalis Pharmaceuticals, Inc.(NasdaqGM:ZNTL) dropped from Russell Small Cap Completeness Index - MarketScreener

Jun 30, 2025

Jun 18, 2025

Zentalis Pharmaceuticals shareholders elect three directors at annual meeting - Investing.com

Jun 18, 2025

Jun 17, 2025

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Receives Average Rating of “Hold” from Brokerages - Defense World

Jun 17, 2025